|
|
|
|
ED50 (µM)a |
Selectivity |
|
|
X |
R |
KB |
KB-VIN |
KB/KB-VIN |
1 |
Desmosdumotin B |
- |
- |
>135 |
6.8 |
>20 |
2 |

|
- |
- |
39.2 |
0.08 |
460 |
3 |

|
O |
- |
>61 |
5.2 |
>12 |
4 |
S |
- |
>58 |
8.7 |
>6.7 |
5 |

|
O |
H |
>61 |
7.9 |
>7.7 |
6 |
S |
H |
50.9 |
3.2 |
16 |
7 |
S |
Me |
37.7 |
27.4 |
1.4 |
8 |

|
- |
- |
51.6 |
15.6 |
3.3 |
9 |

|
- |
- |
>59.0 |
42.8 |
>1.4 |
10 |

|
- |
- |
>33 |
>33 |
1 |
11 |

|
- |
- |
30.8 |
8.3 |
3.7 |
NSC73306b |
|
|
10.65 (KB-3-1) |
1.47 |
7.3 |
Paclitaxel |
|
|
0.007 |
1.77 |
0.004 |
|
aCytotoxicity as ED50 values for each cell line, the concentration of compound that caused 50% reduction in absorbance at 562 nm relative to untreated cells using the sulforhodamine B assay. Epidermoid carcinoma of the nasopharynx (KB), and MDR line overexpressing P-glycoprotein (KB-VIN).bThe data were cited from ref [10] |
Table 1: Activity of 1–11against KB and KB-VIN |